These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10321928)

  • 1. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R
    Bone; 1999 May; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C
    J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone mineral measurement in Paget's disease].
    Nuti R; Vattimo A
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):141-5. PubMed ID: 737061
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical measurements in Paget's disease of bone.
    Russell RG; Colwell A; Hannon RA; Blumsohn A; al-Dehaimi AW; Assiri AM; Peel NF; Eastell R
    Semin Arthritis Rheum; 1994 Feb; 23(4):240-1. PubMed ID: 8009238
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S; Coupland CA; Stone MD; Hosking DJ
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 12. Paget's disease of bone.
    Smith R
    J Bone Joint Surg Br; 1995 Sep; 77(5):673-4. PubMed ID: 7559686
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone (osteitis deformans): symptomatic lesions and bone scan.
    Khairi MR; Wellman HN; Robb JA; Johnston CC
    Ann Intern Med; 1973 Sep; 79(3):348-51. PubMed ID: 4748251
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
    Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
    Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E; Meunier PJ
    Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Paget's disease--taming the wild osteoclast.
    Deftos LJ
    N Engl J Med; 2005 Sep; 353(9):872-5. PubMed ID: 16135831
    [No Abstract]   [Full Text] [Related]  

  • 19. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.